• CIIX records sharply higher investor relations revenue in 1Q2018 and FY2017 as it expands program offerings for branding clients
• In FY2018, company will focus on new cryptocurrency division as it increases commitment to bitcoin education and hosts bitcoin ATM in lobby of its San Gabriel, California, headquarters
• Warren Wang, CEO of CIIX, sets goal of profitability in FY2018

ChineseInvestors.com, Inc. (OTCQB: CIIX) remains diverse, but it has realigned and set a goal of profitability in FY2018 as it increases its core investor relations revenues and offerings while reaffirming its educational services in its cryptocurrency division and its commitment to bitcoin (http://ibn.fm/TL4Cn).

CIIX revenues from investor relations grew in 1Q2018 to $258,366, up 186 percent from the $90,312 it recorded in 1Q2017. In FY2017, CIIX investor relations sales grew to $808,362, 130 percent higher than the $351,615 in FY2016 (http://ibn.fm/oNO9v). The company is expanding its program with such things as branding roadshows. It is also more selective in choosing its client companies and is entering into more cash compensation arrangements.

The company’s clients include those whose shares are traded in various public markets, including the OTCQB Venture Market, NASDAQ and NYSE. CIIX also provides consulting services, such as advertising and public relations support services, to smaller private companies considering going public.

CIIX is a diverse educational and consulting company whose audience is the global Chinese-speaking community. Its primary revenue streams include subscriptions and investor relations. Most recently, it introduced a new cryptocurrency division focused on the education of investors and potential investors regarding bitcoin. Warren Wang, CEO of CIIX, has set a goal of achieving profitability for CIIX in FY2018.

The company’s cryptocurrency division will focus on educational services for Chinese-speaking investors. Currently, that division includes a daily video from the NYSE, titled ‘Bitcoin Multimillionaire’, and CIIX has hosted a bitcoin ATM in the lobby of its San Gabriel, California, headquarters (http://ibn.fm/O9z98).

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Holds 6 U.S. patents covering biosynthesis of cannabinoids, including first U.S. issued patent to create water-soluble cannabinoids
• Aggressively seeking intellectual property patent protection in key countries worldwide
• Able to manufacture kilogram quantities of 18 naturally occurring cannabinoids through biosynthetic processes
• Canadian subsidiary holds controlled substances license from Health Canada

Teewinot Life Sciences is an international biopharmaceutical company focused on the use of synthetic biology and advanced formulation for the production and implementation of cannabinoid-based therapies. Headquartered in Tampa, Florida, Teewinot is a global leader in the formulation, manufacturing and delivery of products containing cannabinoids, cannabinoid prodrugs, and cannabinoid analogs. The company’s wholly owned subsidiaries in Ireland and Canada, along with collaborations formed with key research institutions, consumer product companies, manufacturers, and local communities, combine cutting-edge scientific research on cannabinoids with an aggressive intellectual property portfolio to create new and improved patient therapies.

Teewinot’s experienced in-house Research and Development team utilizes a powerful array of technologies for the efficient and cost-effective production of authentic cannabinoids, cannabinoid pro-drugs and cannabinoid analogs. By combining synthetic biology, biocatalysis, chemical synthesis, bioinformatics and metabolomics, authentic cannabinoids are produced that have the identical chemical structure of cannabinoids naturally produced in the cannabis plant in small quantities. Through its partnerships with leading universities and pharmaceutical companies, Teewinot is working to move the development of these proprietary compounds into clinics to provide novel patient therapies.

Full Spectrum Laboratories Ltd. and Canadian Medical Hemp Biotechnologies, Inc., Teewinot’s wholly owned subsidiaries who develop its proprietary and cost-effective methods for biosynthesis of cannabinoids, are in strict compliance with all applicable government regulations within each operating jurisdiction. Canadian Medical Hemp Biotechnologies, Inc., located near Winnipeg, Manitoba, Canada, holds a controlled substances license from Health Canada to work with cannabinoids. A recently expanded main laboratory facility houses significant research capacities in the fields of microbiology, molecular biology, chemistry, genetics and formulation technologies. A planned expansion into a second laboratory in Vancouver, British Columbia, Canada, will further enhance in-house capabilities in synthetic biology, biosynthesis, biocatalysis, microbiology and organic chemistry.

Full Spectrum Laboratories Ltd., headquartered in Dublin, Ireland, owns the corporation’s intellectual property and is engaged in licensing activities. FSL’s location within the European Union provides beneficial access to significant global markets.

Teewinot enjoys commercial first-mover advantage in the field of cannabinoid biosynthesis with patents covering biosynthetic processes and equipment for the manufacture of cannabinoids, as well as water-soluble cannabinoid formulation technology. Teewinot’s disciplined approach to research and development targets specific applications, which allows for customized product solutions and formulation challenges. Teewinot is available to assist commercial partners in the development or manufacture of new cannabinoid-based pharmaceuticals, prodrugs or analogs.

Teewinot has assembled a veteran management team with demonstrated success in leadership, growth, pharmaceutical development, marketing and aftermarket support. The organization includes a team of highly experienced scientists, business people, attorneys and other support personnel who are carefully aligning the intellectual property strategy with business goals and scientific developments. Teewinot President, Director and CEO Jeffrey M. Korentur is a co-founder of the company with more than 25 years of experience in leadership position in military and private sector roles. He is joined by Richard Peet, J.D., Ph.D., who serves as the chief intellectual property counsel; Bryan K. Brink, vice president of finance; Dr. Malcolm Kavarana, chief scientific officer and senior director intellectual property; and Eric A. Walker as chief information officer.

Teewinot’s strengths lie in its commitment to innovative research that unlocks the medicinal properties found within the cannabis plant, its disciplined approach to research and development with targeted applications, and its determination to connect and collaborate with research institutions, consumer product companies, manufacturers, local communities, and team members. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid based medicines.

For more information, visit the company’s website at www.TLSCorp.com

Let us hear your thoughts: Teewinot Life Sciences Message Board

• Global mobile online gaming activities estimated at $48.3 billion in 2018
• Cutting edge Universal Mobile Interface ™ allows full service in any mobile device
• Competitive advantage in mobile markets driven by company’s rich history in FinTech lead transaction processing
• End-to-end FinTech solution for various vertical markets

Consorteum Holdings, Inc. (OTC: CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

For more information, visit the company’s website at www.Consorteum.com

Let us hear your thoughts: Consorteum Holdings, Inc. Message Board

• Biotech company focused on production of cutting-edge industrial hemp, cannabis/cannabidiol (CBD) products
• R&D efforts include nutraceuticals, pharmaceuticals, bioceuticals, phytoceuticals and cosmeceuticals catering to health, wellness and alternative medicine markets
• International provisional patent application targets CBD’s powerful medicinal benefits
• Integration of CBD molecule with generic drug molecules opens new medical frontier
• U.S. consumer market for cannabinoid-based pharmaceuticals estimated at $50 billion by 2029
• Medical diagnostic device MSN-2 slated for clinical tests to validate detection of various STDs
• Global market for diagnostic testing of STDs expected to reach $108.5 billion by 2019

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

• Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
• Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
• KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

For more information, visit the company’s website at www.EarthScienceTech.com

• Developing series of blockchain technology initiatives to augment existing proprietary big data analytics
• 100 billion daily data computations with 2 million user sessions per month
• Licensing agreements with leading financial news agencies, web portals, stock exchanges
• AI market estimated at $16 billion by 2022 at a CAGR of 62.9% from 2016 to 2022

AnalytixInsight (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

For more information, visit the company’s website at www.AnalytixInsight.com

Let us hear your thoughts: AnalytixInsight Inc. Message Board

• State-licensed online unsecured consumer loan company
• Attractive alternative to expensive payday lenders
• Cumulative loan volume increased to more than $16 million end of 2017
• Since January 2015, cumulative loan volume has increased by 192%

IEG Holdings Corp. (OTCQB: IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand “Mr. Amazing Loans.” Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company’s Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company’s loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans’s terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer’s checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH’s other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings’ chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young’s 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting.

For more information, visit the company’s website at www.InvestmentEvolution.com

Let us hear your thoughts: IEG Holdings Corporation Message Board

• SinglePoint capitalizing on exceptional growth in legal cannabis and cryptocurrency markets via its subsidiary, SingleSeed
• Bitcoin price has increased from $1,000 to over $15,000 in the last year
• Legal cannabis market forecast to reach more than $63 billion by 2024

A diversified holding company with operations in multiple industries and verticals, SinglePoint, Inc. (OTC: SING) is focused on providing full-service mobile technology solutions by capitalizing on two high-performing market sectors, legal cannabis and cryptocurrencies. Over the past year, the price of bitcoin has exploded, from just over $1,000 in January 2017 to over $15,000 on January 9, 2018. The legal cannabis market has also seen significant growth with increasing legalization in North America and Europe, and it’s projected to reach over $63 billion in global sales by 2024, up from just over $14 billion in 2016 (http://dtn.fm/klE6A).

SinglePoint will proceed with a full launch of its subsidiary, SingleSeed, during the first quarter of 2018 to provide a platform for retailers and consumers in the legal cannabis industry to process cryptocurrency payments. Based on blockchain technology, the SingleSeed platform is a proprietary payment processing app that enables payment by bitcoin instead of conventional currency. Blockchain technology facilitates a more efficient, faster and more secure payment process, as well as providing an alternative to many operators in the cannabis sector that don’t have access to traditional banking processes.

Apart from facilitating cryptocurrency payments, the SingleSeed app enables merchants to upload photos and descriptions of their products, and track and update inventories. The app is user-friendly, providing an easy, efficient account registration process to facilitate immediate point-of-sale transactions. The platform also enables dispensaries to use it for text message marketing in order to develop customer relationships and build trust.

While SingleSeed was designed to provide a payment solution to the cannabis industry, it is not industry-specific, and SinglePoint will be able to customize the platform for any industry application in the future. SinglePoint’s proprietary payments solution is currently based on bitcoin, but the company intends to accommodate ethereum in the near future. Currently priced at over $1,200, ethereum could triple in value by the end of the year, according to co-founder Steven Narayoff (http://dtn.fm/Nsw70). SinglePoint’s ultimate goal is to accommodate payments by both cryptocurrencies within its integrated mobile solutions for use by enterprises of all kinds.

With a market cap of over $100 million, SinglePoint is focused on acquisitions of small to medium-sized companies that have developed innovative technologies to expand its portfolio, with a view of providing investors with investment opportunities across a wide range of assets. On December 5, 2017, the company announced a joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. Based on IoT technology, SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. As part of the joint venture agreement, SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions. SinglePoint also entered joint venture agreements with Global Payout (OTC: GOHE) and AppSwarm (OTC: SWRM) last year to strengthen its cryptocurrency payment services and to provide value-added solutions, including licensed in-home delivery services.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

• Standard Lithium recently completed option agreement on 33,000-acre lease in longtime commodities-producing region
• Company expects existing historical data to streamline quick turnaround in resource estimates
• Lithium exploration gaining popularity as tech industry companies seek to shore up supply lines
• Recent drilling order announcement clearly puts Administration on side of energy industry

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is exploring the possibility that oil resource-rich Southern Arkansas could become a large source of lithium amid demands for the modern tech commodity.

Since 1920, the Smackover region’s oil fields near the state’s boundary with Louisiana have been a major employer, even though the boom years ended about a decade after the first large discovery. The oilfield brine byproduct was long considered a nuisance, but, in time, it came to be celebrated for chemicals with fire-retardant properties. Following a second round of mineral exploration, Arkansas has become the world’s largest producer of bromine.

A modern need to augment the scarce mineral resources that make up the high-tech, high-efficiency lithium-ion batteries in so many mobile phones and other Internet-connected consumer electronics, as well as electric vehicles, is fueling what could become a game-changing third round of mineral excitement in the region. Automakers and other companies competing in a global marketplace are jostling with each other to secure a steady supply chain well before an actual need for more lithium-ion battery components exists.

Lithium-ion batteries are also significant players in mass storage systems for electrical power grid operators. As the systems look for longer capacity in their storage technology, lithium is expected to remain a key player (http://dtn.fm/uHC8w), particularly as the cost of the batteries continues to fall. However, electric vehicles and governmental demands for ‘clean energy’ are expected to dominate the market for the batteries in the coming decade or more.

Standard Lithium, which considers part of its mission to minimize resource and political risks in its exploration efforts, considers the 33,000 acres of Smackover Formation brine leases it signed an option agreement for this month to be fertile ground, given the area’s long history of brine production; significant existing infrastructure; access to roads, power and water; and the trained workforce in the region, as well as its existing brine extraction, processing and re-injection permitting regime.

“Due to the wealth of already-available data from our new project area, we can start the process of compiling a maiden resource estimate for this large lease package extremely quickly, with a minimum of additional intrusive investigation,” President and COO Andy Robinson stated in a news release about the agreement issued on January 8 (http://dtn.fm/Pgrm1).

The existing infrastructure and data would allow Standard Lithium its best chance of quickly adding resources to its assets.

The company states that Arkansas produces the equivalent of 42.6 million cubic meters, or 9.38 billion gallons, of brine per year, based on the Arkansas Oil and Gas Commission’s reported average brine production from between 2010 and 2016. Almost all of those billions of gallons of brine came from the Smackover Formation.

The Smackover Formation itself extends through Texas, Arkansas and Louisiana, and it has produced billions of barrels of brines during the last eight decades from an “extensive and extremely well characterized” aquifer, according to the company’s analysis.

Standard Lithium also has a significant lithium exploration project under way in Southern California’s Mojave Desert. Having a large domestic source for lithium-ion batteries would help satisfy concerns about a secure supply chain in United States markets that currently see half of their lithium supply come from imports. According to the U.S. Geological Survey, the United States reported only 38,000 tons of defined lithium reserves.

“The U.S. has a lot more untapped lithium resources than economically mined reserves at this point,” USGS mineral commodity specialist Brian Jaskula said in a February report (http://dtn.fm/hAv4t). In addition, the recent government order opening offshore waters to drilling (http://dtn.fm/Wd23D) is a clear indication of Administration support for the overall tapping of oil resources.

For more information, visit the company’s website at http://nnw.fm/standardlithium

• GRCK front-and-center in booming CBD market, which is expected to reach $2.1 billion in annual sales by 2020
• The company provides current and comprehensive information via its CBD Marketplace and CBD TV channel.
• Learning center articles explore various topics, including the benefits of CBD oil for various conditions

Grey Cloak Tech, Inc. (OTCQB: GRCK) is front-and-center in the rapidly-growing medical cannabis market and poised with one-stop information solutions and new age products and services as awareness increases regarding the potential health benefits of cannabinoids.

The timing is right to position GRCK and its wholly-owned subsidiary, Eqova Life Sciences, in a market with CBD products that are projected to grow at an astronomical rate of 700 percent and reach annual sales of $2.1 billion by 2020 (http://dtn.fm/o0BlF). The company is leading strides in this sector by providing comprehensive and current information with the recent launch of a new and cutting-edge internet CBD Marketplace and CBD TV channel.

The online marketplace (www.CBD.co) offers a new-era gateway into all things CBD and hemp oil, including a learning center, e-commerce, and bot/messaging help functionality. The learning center offers information and research articles that explore various topics, such as the differences between CBD and THC and dosage guides. Educational articles offer tantalizing details on the potential benefits of CBD oil for various conditions ranging from pain, migraines, arthritis and anxiety to epilepsy. They also explore safety of its use for children and pets.

Through the marketplace, customers have access to purchase the company’s wide variety of CBD products, including oils, skincare soaps, balms and solutions, vapes and pet products. Transactions are secure, and the marketplace offers engaging and well-organized content, user-friendly navigation and added customer-centric enhanced capabilities with instant bot/messaging help.

In addition, GRCK just launched the company’s brand new YouTube channel, CBD TV (www.CBD.co/tv), as another valuable source for current information. The channel will feature a wide array of content, including educational videos and in-house staff product reviews, as well as interviews with industry leaders and top executives in the CBD and hemp markets. Speaking to the strategy leading to the creation of the new channel, Grey Cloak’s Director of Content and Research, Nicole Gleichmann, stated in a news release, “Frankly, there is no ‘go-to’ source of reliable information on CBD or hemp on the web. Thus, it’s a great honor to bring the CBD Learning Center and CBD TV to the public.”

Gleichmann further indicated that the timing could not be better for the launch. With the sector’s rapid growth and the use of new products and therapies implementing CBD and hemp, now is indeed a good time to poise the company in a market vying to meet increasing demand.

For more information, visit the company’s website at www.GreyCloakTech.com

Let us hear your thoughts: Grey Cloak Tech, Inc. Message Board

• Lexaria’s CEO posts end of 2017 summary
• Multiple transformative developments – IP strengthened, broad patents awarded, finances secured
• Foundation for the future established – multiple opportunities on horizon

If the past is any prologue, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) should have a break out year in 2018. Lexaria’s CEO, Chris Bunka, recently posted ‘LXRP CEO’s End of 2017 Summary’. It was a transformative year with multiple accomplishments that should establish a strong foundation for the future.

Lexaria Bioscience has developed, patented and commercialized a cost-effective lipophilic delivery technology, DehydraTECH™, to enhance the performance of beneficial compounds in ingestible products. Already scientifically proven to enhance absorption of orally ingested cannabinoids, Lexaria’s novel drug delivery platform is believed to be applicable across a wide range of different vitamins, drug types and cannabinoids, dramatically impacting bio-absorption and bioavailability, as well as taste, smell and speed of action.

Lexaria’s DehydraTECH™ technology is a potential game changer for the delivery methodologies of many commonly used active pharmaceutical substances. The technology provides an additional layer of effectiveness designed to harmonize with the intellectual properties of manufacturers, and it can be used with both patented and generic pharmaceutical substances. This breakthrough plays into Lexaria’s long term strategy to partner with leading pharmaceutical, biopharma, nutraceutical, vitamin and food companies to make payload delivery more predictable, safer and more effective.

The first item addressed in the CEO summary was company finances. With a commitment to enhancing shareholder value, Lexaria cleaned up its balance sheet, raised well over $4 million and paid off all its debt. With cash in the bank, the company announced a $1 million budget for R&D using its patented DehydraTECH™ absorption and palatability-enhancing technology to create even more long term value. The company continued multiple absorption tests and formulation experiments, and it continues to pursue a number of intellectual property (IP) enhancement procedures to expand its IP portfolio.

The most significant and transformational developments of 2017 centered on the incredible value created with Lexaria’s intellectual properties. Late in 2016, Lexaria received its first U.S. patent award. Then, in the first half of 2017, the company received its first patent award in Australia. Lexaria announced in November that it had received a broad ranging U.S. patent award for its DehydraTECH™ as a delivery platform for a wide variety of active pharmaceutical ingredients. The U.S. patent includes all cannabinoids including THC, fat soluble vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine. Lexaria is continuing to advance all of its 33 other patent applications pending around the world. The impact of these patents not only creates value and validates Lexaria’s technology; it also opens untold avenues of business opportunity, some of which may be realized over the course of the coming year.

Lexaria has also taken large positions in subsidiary companies that could benefit from the global liberalization of cannabis. Lexaria owns 50 percent of Ambarii Trade Corp., which may offer international opportunities for a class of mouth-melt consumer products delivered with Lexaria’s technology. Lexaria consolidated ownership of PoViva Tea LLC and now own 100 percent. The company also successfully introduced TurboCBD™, a 100 percent-owned brand of hemp oil empowered with DehydraTECH™.

The company’s stock has performed well over the last year and, given all the progress, may outperform in 2018. Lexaria up-listed to the larger, more recognized OTCQX market, and the company filed an S4 prospectus to re-domicile the company from the U.S. to Canada in an effort to exploit opportunities in the Canadian cannabinoid products sector.

As the abundance of good news from last year begins to sink in, it certainly appears that Lexaria is making all the right moves to make 2018 even better.

For more information, visit the company’s website at www.LexariaBioscience.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board